The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA SequencingTianyu Guo, Yong‐Jie Lu, Elzbieta Stankiewicz et al.|Frontiers in Cell and Developmental Biology|2021Cited by 64
Zanzalintinib (XL092) plus nivolumab in non-clear cell renal cell carcinoma: The randomized phase 3 STELLAR-304 study.Sumanta Kumar Pal, Cristina Suárez, Thomas Powles et al.|Journal of Clinical Oncology|2024Cited by 1